Insulin resistance and lipid levels in adolescents with familial risk for psychosis

Acta Psychiatrica Scandinavica

Volumn 117, Issue 5, 2008, Pages 337-341

  Koponen, H ^a   Maki P ^b   Halonen, H ^b   Miettunen, J ^b   Laitinen, J ^c   Tammelin, T ^c   Moilanen, I ^b   Taanila, A ^b   Ruokonen, A ^b   Korkeila, J ^d,e   Veijola, J ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e Harjavalta Hospital   (Finland)

Author keywords

Cholesterol; Familial risk; Glucose; Insulin resistance; Psychosis; Triglycerides

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; CLINICAL EXAMINATION; COMORBIDITY; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; REGISTER; RISK FACTOR; STATISTICAL ANALYSIS; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CATCHMENT AREA (HEALTH); CHILD; CHOLESTEROL; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; MALE; MOTHERS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS;

EID: 41849127512     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2008.01154.x     Document Type: Article

References (29)

1. Straus MJM, Bleumink GS, Dieleman JP et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004 164 : 1293 1297.
2. Heilä H, Haukka J, Suvisaari J, Lönnqvist J. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 2005 35 : 725 732.
3. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia. Is the differential mortality gap worsened over time? Arch Gen Psychiatry 2007 64 : 1123 1131.
4. Isohanni M, Lauronen E, Moilanen K et al. Predictors of schizophrenia. Evidence from the Northern Finland 19766 Birth Cohort and other sources. Br J Psychiatry 2005 187 (suppl. 48 s4 s7.
5. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiat Scand 2006 113 : 247 272.
6. Sorensen HJ, Mortensen EL, Reinish JM, Mednick SA. Height, weight and body mass index in early adulthood and risk of schizophrenia. Acta Psychiatr Scand 2006 114 : 49 54.
7. Cook S, Weizman M, Auinger P, Nguyen M, Dietz WH. Prevalence of metabolic syndrome phenotype in adolescents. Acta Pediatr Adolesc Med 2003 157 : 821 827.
8. Mikkola I, Keinänen-Kiukaanniemi S, Laakso M et al. Metabolic syndrome in connection with BMI in young Finnish male adults. Diabetes Res Clin Practice 2007 76 : 404 409.
9. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005 115 : 290 296.
10. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007 92 : 399 404.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summery of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
12. Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005 366 : 1059 1062.
13. Saari K, Lindeman S, Viilo K et al. A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort Study. J Clin Psychiatry 2005 66 : 559 563.
14. Correll CU, Frederickson AM, Kane JM, Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J Clin Psychiatry 2006 67 : 575 583.
15. Newcomer JW. Medical risk in patients with bipolar disorder and schizophrenia. J Clin Psychiatry 2006 67 : e16.
16. Thakore JH. Metabolic syndrome and schizophrenia. Br J Psychiatry 2005 186 : 455 456.
17. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003 160 : 284 289.
18. Cohn TA, Remington G, Zipursky RB, Azad A, Connolly P, Wolever TM. Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report. Can J Psychiatry 2006 51 : 382 386.
19. Saari K, Lindeman S, Koponen H, Jokelainen J, Isohanni M. Higher serum triglyceride levels in early-onset schizophrenia. Am J Psychiatry 2004 161 : 176.
20. Järvelin MR, Elliott P, Kleinschmidt I et al. Ecological and individual predictors of birthweight in a northern Finland birth cohort 1986. Paediatr Perinat Epidemiol 1997 11 : 298 312.
21. Tammelin T, Ekelund U, Remes J, Näyhä S. Physical activity and sedentary behaviours among Finnish youth. Med Sci Sports Exerc 2007 39 : 1067 1074.
22. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrin Metab 2000 85 : 2402 2410.
23. Tenerz A, Norhammar A, Silveira A et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003 26 : 2770 2776.
24. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: assessment instruments. Acta Psychiatr Scand 2006 113 : 273 282.
25. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of metabolic syndrome phenotype in adolescents. Arch Pediatr Adolesc Med 2003 157 : 821 827.
26. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006 295 : 1549 1555.
27. Isohanni M, Mäkikyrö T, Moring J et al. A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1997 32 : 303 308.
28. Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents. Diabetes Care 2004 27 : 314 319.
29. St. Clair L, Ballantyne CM. Biological surrogates for enhancing cardiovascular risk prediction in type 2 diabetes mellitus. Am J Cardiol 2007 99 (suppl. 80B 88B.